Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   TEVA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
TEVA PHARMA
Dec-13
IPCA LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0623,459-   
Low Rs7683,005-   
Sales per share (Unadj.) Rs243.01,985.4-  
Earnings per share (Unadj.) Rs19.4124.0-  
Cash flow per share (Unadj.) Rs29.7284.5-  
Dividends per share (Unadj.) Rs4.00108.57-  
Avg Dividend yield %0.43.4 13.0%  
Book value per share (Unadj.) Rs230.32,205.4-  
Shares outstanding (eoy) m253.70848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.6 231.3%   
Avg P/E ratio x47.226.1 181.1%  
P/CF ratio (eoy) x30.811.4 271.2%  
Price / Book Value ratio x4.01.5 271.1%  
Dividend payout %20.687.5 23.6%   
Avg Mkt Cap Rs m232,1202,741,007 8.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m12,8760-   
Avg. sales/employee Rs Th037,459.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,340.1-  
INCOME DATA
Net Sales Rs m61,6421,683,624 3.7%  
Other income Rs m1,5180-   
Total revenues Rs m63,1601,683,624 3.8%   
Gross profit Rs m9,033461,061 2.0%  
Depreciation Rs m2,616136,089 1.9%   
Interest Rs m48233,069 1.5%   
Profit before tax Rs m7,453291,903 2.6%   
Minority Interest Rs m01,326 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-191,619 -0.0%   
Tax Rs m2,534-3,564 -71.1%   
Profit after tax Rs m4,919105,175 4.7%  
Gross profit margin %14.727.4 53.5%  
Effective tax rate %34.0-1.2 -2,784.4%   
Net profit margin %8.06.2 127.7%  
BALANCE SHEET DATA
Current assets Rs m51,8931,137,114 4.6%   
Current liabilities Rs m18,058991,659 1.8%   
Net working cap to sales %54.98.6 635.3%  
Current ratio x2.91.1 250.6%  
Inventory Days Days5191 56.4%  
Debtors Days Days696 6.1%  
Net fixed assets Rs m34,336549,909 6.2%   
Share capital Rs m2544,144 6.1%   
"Free" reserves Rs m58,1670-   
Net worth Rs m58,4201,870,187 3.1%   
Long term debt Rs m6,518860,875 0.8%   
Total assets Rs m86,2293,847,621 2.2%  
Interest coverage x16.59.8 167.6%   
Debt to equity ratio x0.10.5 24.2%  
Sales to assets ratio x0.70.4 163.4%   
Return on assets %6.33.6 174.3%  
Return on equity %8.45.6 149.7%  
Return on capital %12.24.9 247.8%  
Exports to sales %42.90-   
Imports to sales %13.30-   
Net fx Rs m18,2570-   
CASH FLOW
From Operations Rs m8,058268,283 3.0%  
From Investments Rs m-7,250-95,063 7.6%  
From Financial Activity Rs m5,072-321,823 -1.6%  
Net Cashflow Rs m5,881-148,604 -4.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare IPCA LABS With: TYCHE INDUSTRIES  MOREPEN LABS  HESTER BIOSCIENCES  PIRAMAL PHARMA  THEMIS MEDICARE  



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.